ViaLase®
News
Check back here for the latest updates on our research and clinical studies, as well as industry coverage about the ViaLuxe™ Laser System.
1 2 Next »April 29, 2026 | Press Release
ViaLase to Present Multiple Scientific Papers at the 2026 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Read MoreDecember 3, 2025 | Press Release
ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle Glaucoma
Read MoreJuly 8, 2025 | Press Release
ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth
Read MoreJuly 30, 2024 | Press Release
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase® Laser
Read MoreApril 1, 2024 | Press Release
ViaLase Closes $40 million Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma
Read MoreSign up for our newsletter below and be sure to follow us on social media.